Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1060 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Aeterna Zentaris sees rise in Q2 revenues

The increase is related to comparative higher-than-normal deliveries of Cetrotide to certain customers, as well as to the comparative strengthening of the euro against the US dollar. The

Eisai chooses Veeva System CRM

The Veeva CRM suite of applications include VBioPharma, iRep, VMobile, and Vinsights. The new CRM system will facilitate Eisai to streamline its computing environment by integrating three of

Prolor gets Israeli grant

The fund has been granted to the Israeli R&D subsidiary of Prolor for the biobetter version of human growth hormone, hGH-CTP. Prolor is responsible to pay back the

Genesis Biopharma signs CRADA with NCI

The agreement aims to develop adoptive cell immunotherapies that are intended to destroy metastatic melanoma cells using a patient’s tumor infiltrating lymphocytes. Under the CRADA, the companies will

GNS Healthcare, BMS sign deal

The tie up allows GNS to use clinical and molecular information from a BMS clinical trial while using its own supercomputer-driven reverse-engineering and forward-simulation (REFS) platform for creating

Glenmark starts Revamilast Phase IIb trials

The trials aim to determine the safety and efficacy profile of the drug in inflammatory disorders. Glenmark has also initiated another global Phase IIb trial with Revamilast in

PRECOS partners RCT for cancer therapy research

The parntership allows PRECOS to validate RCT’s existing research using its validated patient relevant cancer models like in vitro 2D and 3D assays, in vivo therapeutic evaluations and

Access Pharma adds CSPN to MuGard sales network

CSPN offers specialty pharmacy services including mail distribution, clinical services, therapy management and web-based reporting. MuGard is a viscous, mucoadhesive rinse which provides a protective coating to the